Lionco Pharmaceutical Group Co., Ltd. Class ASSE: 603669

Announcement on Subsidiary's Vecuronium Bromide for Injection Passing Generic Drug Consistency Evaluation

· Issued by Lionco Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary's Vecuronium Bromide for Injection Passing Generic Drug Consistency Evaluation

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment